Magnhild Sandberg Wollheim
1 – 38 of 38
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Pregnancy outcomes from the Branded glatiramer acetate pregnancy database
(
- Contribution to journal › Article
- 2013
-
Mark
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
(
- Contribution to journal › Debate/Note/Editorial
- 2011
-
Mark
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
(
- Contribution to journal › Article
-
Mark
The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings.
(
- Contribution to journal › Article
-
Mark
Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a Therapy.
(
- Contribution to journal › Article
- 2010
-
Mark
Evaluation of the risk of malignancy in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
2010) 20th Meeting of the European-Neurological-Society In Journal of Neurology 257(Suppl. 1). p.44-44(
- Contribution to journal › Published meeting abstract
-
Mark
Associations between annualized relapse rate and long-term exposure to subcutaneous interferon beta-1a in the Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study
2010) 20th Meeting of the European-Neurological-Society In Journal of Neurology 257(Suppl. 1). p.456-456(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
(
- Contribution to journal › Article
-
Mark
Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Nordic trial of methylprednisolone as add-on therapy to interferon-beta for the treatment of relapsing-remitting multiple sclerosis
2008) 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis In Multiple Sclerosis Journal 14. p.299-300(
- Contribution to journal › Published meeting abstract
-
Mark
Cognitive dysfunction 24-31 years after isolated optic neuritis.
(
- Contribution to journal › Article
-
Mark
Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A follow-up study of Nordic multiple sclerosis candidate gene regions
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Article
- 2006
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
(
- Contribution to journal › Article
- 2005
-
Mark
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis - The EVIDENCE study
(
- Contribution to journal › Article
-
Mark
Interferon-beta1a treatment for multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis The EVIDENCE study.
(
- Contribution to journal › Article
-
Mark
Predicting the Outcome of Optic Neuritis Evaluation of risk factors after 30 years of follow-up.
(
- Contribution to journal › Article
-
Mark
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
(
- Contribution to journal › Article
-
Mark
Neutralizing antibodies and efficacy of interferon beta-1a - A 4-year controlled study
(
- Contribution to journal › Article
-
Mark
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria"
(
- Contribution to journal › Article
- 2004
-
Mark
No evidence for genetic linkage between development of multiple sclerosis and components of the IFN system and the JAK-STAT pathway.
(
- Contribution to journal › Article
-
Mark
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
(
- Contribution to journal › Article
-
Mark
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
(
- Contribution to journal › Article
- 2003
-
Mark
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
(
- Contribution to journal › Article
- 2002
-
Mark
International consensus statement on the use of disease-modifying agents in multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
(
- Contribution to journal › Article
-
Mark
A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis
(
- Contribution to journal › Article
- 1991
-
Mark
Analysis of peripheral blood lymphocyte phenotype and function during dexamethazone treatment of progressive multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4
(
- Contribution to journal › Article
- 1990
-
Mark
A long-term prospective study of optic neuritis: evaluation of risk factors
(
- Contribution to journal › Article
- 1988
-
Mark
Mononuclear cells recovered from inflammatory synovial membrane using fine-needle biopsy
(
- Contribution to journal › Article
-
Mark
Astrocytoma grade III and IV
1988) p.124-127(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1987
-
Mark
Hyaluronidase treatment of synovial fluid affects the recovery of mononuclear cells and their in vitro immunoglobulin synthesis
(
- Contribution to journal › Article